Nadezhda Andreevna Levdarovich

Ms. Nadezhda Andreevna Levdarovich

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MRMaxim Rabchinskii
Maxim Rabchinskii
ADArthur T. Dideikin
Arthur T. Dideikin
DKDemid Kirilenko
Demid Kirilenko
MBMarina V. Baidakova
Marina V. Baidakova
VSVladimir V. Shnitov
Vladimir V. Shnitov
Alexander Ya VulAlexander Ya Vul
Alexander Ya Vul
This paper reports a facile and green method for conversion of graphene oxide (GO) into graphene by low-temperature heating (80 °C) in the presence of a glass wafer. Compared to conventional GO chemical reduction methods, the presented approach is easy-scalable, operationally simple, and based on the use of a non-toxic recyclable deoxygenation agent. The efficiency of the proposed method is further expanded by the fact that it can be applied for reducing both GO suspensions and large-scale thin films formed on various substrates prior to the reduction process. The quality of the obtained reduced graphene oxide (rGO) strongly depends on the type of the used glass wafer, and, particularly, magnesium silicate glass can provide rGO with the C/O ratio of 7.4 and conductivity of up to 33000 S*cm−1. Based on the data obtained, we have suggested a mechanism of the observed reduction process in terms of the hydrolysis of the glass wafer with subsequent interaction of the leached alkali and alkali earth cations and silicate anions with graphene oxide, resulting in elimination of the oxygen-containing groups from the latter one. The proposed approach can be efficiently used for low-cost bulk-quantity production of graphene and graphene-based materials for a wide field of applications.

2 May 2022 in Carbon
Verified
Journal Article
Closed access
MRMaxim K. Rabchinskii
Maxim K. Rabchinskii
SRSergey A. Ryzhkov
Sergey A. Ryzhkov
NLNadezhda Andreevna Levdarovich
Nadezhda Andreevna Levdarovich
Maria BrzhezinskayaMaria Brzhezinskaya
Maria Brzhezinskaya
MMMaxim N. Malkov
Maxim N. Malkov
Brunkov Pavel NikolaevichBrunkov Pavel Nikolaevich
Brunkov Pavel Nikolaevich

31 January 2023 in Biology
Verified
Journal Article
Open access
PDF file
ESElisaveta Skverchinskaya
Elisaveta Skverchinskaya
NLNadezhda Andreevna Levdarovich
Nadezhda Andreevna Levdarovich
AIAlexander Ivanov
Alexander Ivanov
Igor MindukshevIgor Mindukshev
Igor Mindukshev
ABAnton Bukatin
Anton Bukatin
Red blood cells (RBCs) are the most numerous cells in the body and perform gas exchange between all tissues. During the infusion of cancer chemotherapeutic (CT) agents, blood cells are the first ones to encounter aggressive cytostatics. Erythrocyte dysfunction caused by direct cytotoxic damage might be a part of the problem of chemotherapy-induced anemia—one of the most frequent side effects. The aim of the current study is to evaluate the functional status of RBCs exposed to mono and combinations of widely used commercial pharmaceutical CT drugs with different action mechanisms: paclitaxel, carboplatin, cyclophosphamide, and doxorubicin, in vitro. Using laser diffraction, flow cytometry, and confocal microscopy, we show that paclitaxel, having a directed effect on cytoskeleton proteins, by itself and in combination with carboplatin, caused the most marked abnormalities—loss of control of volume regulation, resistance to osmotic load, and stomatocytosis. Direct simulations of RBCs’ microcirculation in microfluidic channels showed both the appearance of a subpopulation of cells with impaired velocity (slow damaged cells) and an increased number of cases of occlusions. In contrast to paclitaxel, such drugs as carboplatin, cyclophosphamide, and doxorubicin, whose main target in cancer cells is DNA, showed significantly less cytotoxicity to erythrocytes in short-term exposure. However, the combination of drugs had an additive effect. While the obtained results should be confirmed in in vivo models, one can envisioned that such data could be used for minimizing anemia side effects during cancer chemotherapy.

25 May 2023 in Nanomaterials
Verified
Journal Article
Open access
PDF file
MRMaxim Rabchinskii
Maxim Rabchinskii
NLNadezhda Andreevna Levdarovich
Nadezhda Andreevna Levdarovich
Maria BrzhezinskayaMaria Brzhezinskaya
Maria Brzhezinskaya
DSDina Yu. Stolyarova
Dina Yu. Stolyarova
SRSergei A. Ryzhkov
Sergei A. Ryzhkov
Brunkov Pavel NikolaevichBrunkov Pavel Nikolaevich
Brunkov Pavel Nikolaevich
The facile synthesis of biografted 2D derivatives complemented by a nuanced understanding of their properties are keystones for advancements in biosensing technologies. Herein, we thoroughly examine the feasibility of aminated graphene as a platform for the covalent conjugation of monoclonal antibodies towards human IgG immunoglobulins. Applying core-level spectroscopy methods, namely X-ray photoelectron and absorption spectroscopies, we delve into the chemistry and its effect on the electronic structure of the aminated graphene prior to and after the immobilization of monoclonal antibodies. Furthermore, the alterations in the morphology of the graphene layers upon the applied derivatization protocols are assessed by electron microscopy techniques. Chemiresistive biosensors composed of the aerosol-deposited layers of the aminated graphene with the conjugated antibodies are fabricated and tested, demonstrating a selective response towards IgM immunoglobulins with a limit of detection as low as 10 pg/mL. Taken together, these findings advance and outline graphene derivatives’ application in biosensing as well as hint at the features of the alterations of graphene morphology and physics upon its functionalization and further covalent grafting by biomolecules.

4 July 2022 in Communications Biology
Verified
Journal Article
Open access
PDF file
NLNadezhda Andreevna Levdarovich
Nadezhda Andreevna Levdarovich
ESElisaveta A. Skverchinskaya
Elisaveta A. Skverchinskaya
SSStanislav V. Shmakov
Stanislav V. Shmakov
AIAlexander S. Ivanov
Alexander S. Ivanov
IMIgor V. Mindukshev
Igor V. Mindukshev
ABAnton Bukatin
Anton Bukatin
Oxidative stress is one of the key factors that leads to red blood cells (RBCs) aging, and impairs their biomechanics and oxygen delivery. It occurs during numerous pathological processes and causes anaemia, one of the most frequent side effects of cancer chemotherapy. Here, we used microfluidics to simulate the microcirculation of RBCs under oxidative stress induced by tert-Butyl hydroperoxide. Oxidative stress was expected to make RBCs more rigid, which would lead to decrease their transit velocity in microfluidic channels. However, single-cell tracking combined with cytological and AFM studies reveals cell heterogeneity, which increases with the level of oxidative stress. The data indicates that the built-in antioxidant defence system has a limit exceeding which haemoglobin oxidation, membrane, and cytoskeleton transformation occurs. It leads to cell swelling, increased stiffness and adhesion, resulting in a decrease in the transit velocity in microcapillaries. However, even at high levels of oxidative stress, there are persistent cells in the population with an undisturbed biophysical phenotype that retain the ability to move in microcapillaries. Developed microfluidic analysis can be used to determine RBCs’ antioxidant capacity for the minimization of anaemia during cancer chemotherapy.

1 January 2018 in Superlattices and Microstructures
Verified
Journal Article
Closed access
SKS.V. Koniakhin
S.V. Koniakhin
NLNadezhda Andreevna Levdarovich
Nadezhda Andreevna Levdarovich
DKDemid Kirilenko
Demid Kirilenko
ASAleksandr Shvidchenko
Aleksandr Shvidchenko
EEE.D. Eidelman
E.D. Eidelman